Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
for Atopic Dermatitis
2 locations in New York
Sponsor: Weill Medical College of Cornell University
Sex: All·Age: 12 - 17
Code: NCT07746427·Recruiting·Listed Aug 5, 2026
Clinical Trials at Columbia University Irving Medical Center
As of September 2026, 156 paid clinical trials are recruiting at Columbia University Irving Medical Center, located at 622 W 168TH ST, PH 8 EAST, ROOM 101, NEW YORK, NY 10032-3720, phone (212) 305-9818 in New York, New York. Active studies at this site cover conditions such as Breast Cancer, Prostate Cancer and Multiple Myeloma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
Newly added in New York
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
157 clinical trials at Columbia University Irving Medical Center
·Clear filters· Get a weekly email when new trials open in New York, NY.
A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
for Adenovirus Infections
Sites in New York, New Hyde Park +30 more locations
Sponsor: SymBio Pharmaceuticals
Sex: All·Age: 2 Months+
Code: NCT07387367·Phase 3·Recruiting·Listed Feb 2026
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
for Clostridoides Difficile Associated Disease
Sites in New York, Brooklyn +138 more locations
Sponsor: Pfizer
Sex: All·Age: 65+·Accepts healthy volunteers
Code: NCT07282665·Phase 3·Recruiting·Listed Dec 2025
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
for Carcinoma, Transitional Cell
Sites in New York, Rochester +62 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07218380·Phase 3·Recruiting·Listed Oct 2025
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
for Healthy
Sites in New York, Jackson Heights +116 more locations
Sponsor: Pfizer
Sex: All·Age: 1 Day - 49·Accepts healthy volunteers
Code: NCT07160244·Phase 3·Recruiting·Listed Sep 2025
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for Carcinoma, Non-Small-Cell Lung
Drug: LY3537982
Sites in New York, Northport +89 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06890598·Phase 3·Recruiting·Listed Mar 2025
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
for Acute Treatment of Migraine
Drug: Rimegepant
Sites in New York, Commack +59 more locations
Sponsor: Pfizer
Sex: All·Age: 6 - 17
Code: NCT04743141·Phase 3·Recruiting·Listed Feb 2021
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
for PIK3CA Mutation
Sites in New York +51 more locations
Sponsor: Relay Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06982521·Phase 3·Recruiting·Listed May 2025
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
for Carcinoma, Non-Small Cell Lung
Drug: sigvotatug vedotin
Sites in New York, Brooklyn +102 more locations
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All·Age: 18+
Code: NCT04389632·Phase 1·Recruiting·Listed May 2020
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
for Melanoma
Sites in New York, Uniondale +56 more locations
Sponsor: Pfizer
Sex: All·Age: 16+
Code: NCT05538130·Phase 1·Recruiting·Listed Sep 2022
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
for Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Sites in New York +36 more locations
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 18 - 75
Code: NCT05519475·Phase 2·Recruiting·Listed Aug 2022
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for Chronic Inflammatory Demyelinating Polyneuropathy
Drug: riliprubart
Sites in New York, Amherst +31 more locations
Sponsor: Sanofi
Sex: All·Age: 18+
Code: NCT06290141·Phase 3·Recruiting·Listed Mar 2024
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
for Advanced Solid Tumor
Sites in New York, Lake Success +22 more locations
Sponsor: Synthekine
Sex: All·Age: 18+
Code: NCT05098132·Phase 1, Phase 2·Recruiting·Listed Oct 2021
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
for Venous Thromboembolism
Sites in New York, Brooklyn +31 more locations
Sponsor: Inari Medical
Sex: All·Age: 18+
Code: NCT05701917·Recruiting·Listed Jan 2023
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
for Cancer Harboring BRAF Alterations
Sites in New York +28 more locations
Sponsor: Fore Biotherapeutics
Sex: All·Age: 8+
Code: NCT05503797·Phase 2·Recruiting·Listed Aug 2022
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
for Type 1 Diabetes Mellitus
Sites in New York, Buffalo +30 more locations
Sponsor: Sanofi
Sex: All·Age: 1 - 25
Code: NCT07088068·Phase 3·Recruiting·Listed Jul 2025
Pompe Disease Registry Protocol
for Glycogen Storage Disease Type II
Sites in New York, New Hyde Park +72 more locations
Sponsor: Genzyme, a Sanofi Company
Sex: All·Age: All ages
Code: NCT00231400·Recruiting·Listed Oct 2005
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
for Myelodysplastic Syndrome
Sites in New York +40 more locations
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All·Age: 18+
Code: NCT04227847·Phase 1·Recruiting·Listed Jan 2020
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
for Liver Neoplasms
Sites in New York, Rochester +25 more locations
Sponsor: HistoSonics, Inc.
Sex: All·Age: 22+
Code: NCT06486454·Recruiting·Listed Jul 2024
A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction
for Lung Transplant Rejection
Sites in New York, The Bronx +30 more locations
Sponsor: Sanofi
Sex: All·Age: 18+
Code: NCT06082037·Phase 3·Recruiting·Listed Oct 2023
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
for Alpha1-Antitrypsin Deficiency
Sites in New York +32 more locations
Sponsor: Takeda
Sex: All·Age: 18 - 75
Code: NCT05677971·Phase 3·Recruiting·Listed Jan 2023
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
for Gaucher Disease
Sites in New York, Manhasset +68 more locations
Sponsor: Genzyme, a Sanofi Company
Sex: All·Age: All ages
Code: NCT00358943·Recruiting·Listed Aug 2006
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
for Relapsed Hematologic Malignancy
Drug: Emavusertib
Sites in New York, Buffalo +16 more locations
Sponsor: Curis, Inc.
Sex: All·Age: 18+
Code: NCT03328078·Phase 1, Phase 2·Recruiting·Listed Nov 2017
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
for COVID-19
Sites in New York, New Hyde Park +22 more locations
Sponsor: Pfizer
Sex: All·Age: 0 - 17
Code: NCT05261139·Phase 3·Recruiting·Listed Mar 2022
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
for Glioblastoma (GBM)
Sites in New York, The Bronx +26 more locations
Sponsor: Black Diamond Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT07326566·Phase 2·Recruiting·Listed Jan 2026
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
for NSCLC Adenocarcinoma
Sites in New York +16 more locations
Sponsor: IDEAYA Biosciences
Sex: All·Age: 18+
Code: NCT07277413·Phase 1·Recruiting·Listed Dec 2025
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
for Bladder Cancer
Sites in New York +14 more locations
Sponsor: EvolveImmune United, Inc
Sex: All·Age: 18+
Code: NCT07217171·Phase 1·Recruiting·Listed Oct 2025
IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
for Relapsed/Refractory Primary Central Nervous System Lymphoma
Drug: Rituximab
Sites in New York +22 more locations
Sponsor: Ono Pharmaceutical Co., Ltd.
Sex: All·Age: 18+
Code: NCT07104032·Phase 3·Recruiting·Listed Aug 2025
A Long-term Follow-up Study in Patients Who Received BEAM-101
for Hemoglobinopathy
Sites in New York +16 more locations
Sponsor: Beam Therapeutics Inc.
Sex: All·Age: 14 - 37
Code: NCT07373639·Recruiting·Listed Jan 2026
Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma
for Relapsed and/or Refractory B-cell Lymphoma
Drug: KITE-753
Sites in New York, Rochester +17 more locations
Sponsor: Kite, A Gilead Company
Sex: All·Age: 18+
Code: NCT04989803·Phase 1, Phase 2·Recruiting·Listed Aug 2021
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
for Metastatic Solid Tumor
Drug: LY4052031
Sites in New York +20 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06465069·Phase 1·Recruiting·Listed Jun 2024
REVEAL: A Phase 3 Study of Obudanersen (ION582) in Angelman Syndrome
for Angelman Syndrome
Sites in New York +17 more locations
Sponsor: Ionis Pharmaceuticals, Inc.
Sex: All·Age: 2 - 50
Code: NCT06914609·Phase 3·Recruiting·Listed Apr 2025
Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)
for Central Line Associated Blood Stream Infections (CLABSI)
Sites in New York +15 more locations
Sponsor: CorMedix Therapeutics
Sex: All·Age: 18+
Code: NCT06822426·Phase 3·Recruiting·Listed Feb 2025
Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant
for Pre-Bronchiolitis Obliterans Syndrome
Sites in New York +19 more locations
Sponsor: Renovion, Inc.
Sex: All·Age: 18 - 75
Code: NCT05654922·Phase 3·Recruiting·Listed Dec 2022
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
for Primary Mitochondrial Disease
Sites in New York +19 more locations
Sponsor: Pharming Technologies B.V.
Sex: All·Age: 18+
Code: NCT05650229·Phase 2·Recruiting·Listed Dec 2022
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
for Systemic Sclerosis
Sites in New York, Rochester +8 more locations
Sponsor: Cabaletta Bio
Sex: All·Age: 18 - 75
Code: NCT06328777·Phase 2, Phase 3·Recruiting·Listed Mar 2024
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
for Metastatic Castration-resistant Prostate Cancer
Sites in New York, New Hyde Park +11 more locations
Sponsor: K36 Therapeutics, Inc.
Sex: Male·Age: 18+
Code: NCT07103018·Phase 1·Recruiting·Listed Aug 2025
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
for Solid Tumor, Adult
Sites in New York +18 more locations
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Sex: All·Age: 18+
Code: NCT06625775·Phase 1·Recruiting·Listed Oct 2024
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
for Non-Small Cell Lung Cancer
Sites in New York +15 more locations
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Sex: All·Age: 18+
Code: NCT06917079·Phase 1·Recruiting·Listed Apr 2025
Pompe Pregnancy Sub-Registry
for Glycogen Storage Disease Type II (GSD-II)
Sites in New York +13 more locations
Sponsor: Genzyme, a Sanofi Company
Sex: Female·Age: All ages
Code: NCT00567073·Recruiting·Listed Dec 2007
Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)
for Alpha1-Antitrypsin Deficiency
Sites in New York +19 more locations
Sponsor: Takeda
Sex: All·Age: 18 - 75
Code: NCT06165341·Phase 3·Recruiting·Listed Dec 2023
Common conditions studied in New York
- Breast Cancer (92 active studies)
- Prostate Cancer (74 active studies)
- Multiple Myeloma (44 active studies)
- Colorectal Cancer (42 active studies)
- Ovarian Cancer (41 active studies)
- Endometrial Cancer (37 active studies)
Leading research sponsors in New York
- Memorial Sloan Kettering Cancer Center
- NYU Langone Health
- Columbia University
- Icahn School of Medicine at Mount Sinai
- Weill Medical College of Cornell University
Frequently asked questions
How many paid clinical trials are currently recruiting in New York?
There are approximately 3,375 recruiting clinical trials in New York, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in New York pay participants?
Most recruiting trials in New York compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in New York?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in New York?
The most common conditions under active study in New York include Breast Cancer (92), Prostate Cancer (74), Multiple Myeloma (44), Colorectal Cancer (42), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in New York?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in New York on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in New York?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in New York?
Recruiting research sites in New York include Memorial Sloan Kettering Cancer Center, NYU Langone Health, Icahn School of Medicine at Mount Sinai, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in New York right now?
The largest active categories in New York are Cancer & tumors (1,129), Neurology & pain (198), Cardiovascular (195). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Columbia University Irving Medical Center?
Columbia University Irving Medical Center is located at 622 W 168TH ST, PH 8 EAST, ROOM 101, NEW YORK, NY 10032-3720. Use the Google Maps link in the intro above to get directions.
How do I contact Columbia University Irving Medical Center?
You can reach Columbia University Irving Medical Center by phone at (212) 305-9818. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.
Browse more clinical trials
Other cities in New York
The Bronx, NY(553)Rochester, NY(474)Buffalo, NY(415)Commack, NY(321)Harrison, NY(301)Uniondale, NY(226)Brooklyn, NY(205)Syracuse, NY(179)Stony Brook, NY(171)Albany, NY(164)Lake Success, NY(146)New Hyde Park, NY(120)Mineola, NY(116)Manhasset, NY(100)Valhalla, NY(97)Rockville Centre, NY(83)Staten Island, NY(77)East Syracuse, NY(57)Mount Kisco, NY(44)White Plains, NY(42)Amherst, NY(37)Bay Shore, NY(32)Flushing, NY(32)Westbury, NY(32)Great Neck, NY(31)Roslyn, NY(31)Webster, NY(29)Poughkeepsie, NY(26)Shirley, NY(26)Queens, NY(25)Long Island City, NY(24)Sleepy Hollow, NY(24)Ithaca, NY(22)Williamsville, NY(22)Glens Falls, NY(19)Garden City, NY(17)New Windsor, NY(17)West Islip, NY(17)Camillus, NY(16)Jamaica, NY(16)Cedarhurst, NY(15)Greenlawn, NY(15)Cooperstown, NY(14)Liverpool, NY(14)Manhattan, NY(14)Binghamton, NY(13)Hawthorne, NY(13)Laurelton, NY(13)Oswego, NY(13)Verona, NY(13)Clifton Park, NY(12)Port Jefferson Station, NY(12)Glen Oaks, NY(11)Rego Park, NY(11)East Hills, NY(10)Syosset, NY(10)East White Plains, NY(9)Huntington, NY(9)Oceanside, NY(9)Old Westbury, NY(9)